<DOC>
	<DOCNO>NCT01002170</DOCNO>
	<brief_summary>In treatment tuberculosis , second-line drug usually less effective drug toxicity first-line one . For multidrug-resistant tuberculosis ( MDR-TB ) patient , resistant major first-line anti-tuberculosis drug Rifampin Isoniazid , second-line agent , like Cycloserine research , frequent use . Taking patient ' safety consideration , therapeutic drug monitoring Cycloserine list routine examination tuberculosis treatment establish suggest Cycloserine serum concentration 20~35 mcg/mL . While suggested drug concentration set , n't suitable race world . The investigator plan develop therapeutic drug monitoring protocol suggest treat concentration fit Asian ( Taiwanese ) . In addition , research , investigator also realize factor cause different pharmacokinetics clinical outcome different Cycloserine level .</brief_summary>
	<brief_title>Pharmacokinetic Study Patients Who Undergo Cycloserine , 2nd-line Antituberculosis Medicament</brief_title>
	<detailed_description>In treatment tuberculosis , second-line drug usually less effective drug toxicity first-line one . For multidrug-resistant tuberculosis ( MDR-TB ) patient , resistant major first-line anti-tuberculosis drug Rifampin Isoniazid , second-line agent , like Cycloserine research , frequent use . Taking patient ' safety consideration , therapeutic drug monitoring Cycloserine list routine examination tuberculosis treatment establish suggest Cycloserine serum concentration 20~35 mcg/mL . While suggested drug concentration set , n't suitable race world . The investigator plan develop therapeutic drug monitoring protocol suggest treat concentration fit Asian ( Taiwanese ) . In addition , research , investigator also realize factor cause different pharmacokinetics clinical outcome different Cycloserine level .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Pulmonary</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<mesh_term>Antitubercular Agents</mesh_term>
	<criteria>5 day Cycloserine take Asians Cancer patient AIDS patient Combined AIDSTB patient Pregnant subject Anyone whose medical medication record unclear</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Tuberculosis</keyword>
	<keyword>Cycloserine</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>